189 related articles for article (PubMed ID: 32980036)
1. Inpatient Adherence to Topical Glaucoma Medications before and after an Educational Intervention.
Mammo DA; Strampe M; Naravane A; Mallory PW; Boysen J; Wright MM
Ophthalmol Glaucoma; 2020; 3(5):339-342. PubMed ID: 32980036
[TBL] [Abstract][Full Text] [Related]
2. Eye-Drop Abstinence in Glaucoma Patients Admitted to the Hospital Service: A Single Institution Assessment.
Nanda T; Tierney P; Blumberg DM
Ophthalmol Glaucoma; 2019; 2(3):188-191. PubMed ID: 32672591
[TBL] [Abstract][Full Text] [Related]
3. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Jefferys JL; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):845-50. PubMed ID: 24831037
[TBL] [Abstract][Full Text] [Related]
4. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Dec; 116(12):2286-93. PubMed ID: 19815286
[TBL] [Abstract][Full Text] [Related]
5. Adherence to topical glaucoma medication during hospitalization.
Yousuf SJ; Jones LS
J Glaucoma; 2011 Dec; 20(9):573-6. PubMed ID: 21048511
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
[TBL] [Abstract][Full Text] [Related]
7. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
[TBL] [Abstract][Full Text] [Related]
8. Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study.
Hollenhorst CN; Elliott V; Heisler M; Schneider K; Resnicow K; Newman-Casey PA
Ophthalmol Glaucoma; 2020; 3(4):238-252. PubMed ID: 33008556
[TBL] [Abstract][Full Text] [Related]
9. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.
Sleath B; Blalock SJ; Carpenter DM; Sayner R; Muir KW; Slota C; Lawrence SD; Giangiacomo AL; Hartnett ME; Tudor G; Goldsmith JA; Robin AL
Ophthalmology; 2015 Apr; 122(4):748-54. PubMed ID: 25542521
[TBL] [Abstract][Full Text] [Related]
10. The Effect of an Educational Intervention on Adherence to Intraocular Pressure-Lowering Medications in a Large Cohort of Older Adults with Glaucoma.
Fiscella R; Caplan E; Kamble P; Bunniran S; Uribe C; Chandwani H
J Manag Care Spec Pharm; 2018 Dec; 24(12):1284-1294. PubMed ID: 29848186
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
[TBL] [Abstract][Full Text] [Related]
12. Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.
Ford BA; Gooi M; Carlsson A; Crichton AC
J Glaucoma; 2013 Jan; 22(1):1-4. PubMed ID: 21946541
[TBL] [Abstract][Full Text] [Related]
13. Adherence to glaucoma medication: the effect of interventions and association with personality type.
Lim MC; Watnik MR; Imson KR; Porter SM; Granier AM
J Glaucoma; 2013 Aug; 22(6):439-46. PubMed ID: 22411021
[TBL] [Abstract][Full Text] [Related]
14. Adherence to topical glaucoma medications in Ethiopian patients.
Tamrat L; Gessesse GW; Gelaw Y
Middle East Afr J Ophthalmol; 2015; 22(1):59-63. PubMed ID: 25624675
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Patient Education and Telemedicine Reminders on Adherence to Eye Drops for Glaucoma.
Lai Y; Wu Y; Chai C; Yen CC; Ho Y; Eng TC; Jain P; Koh V
Ophthalmol Glaucoma; 2020; 3(5):369-376. PubMed ID: 32980041
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy of the After-visit Summary in Medication Recall Among Glaucoma Patients.
Hirabayashi KJ; Pomerantz M; Radell JE; Chadha N; Thomas S; Serle JB
J Glaucoma; 2020 Jul; 29(7):529-535. PubMed ID: 32332333
[TBL] [Abstract][Full Text] [Related]
17. Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma.
Dave P; Villarreal G; Friedman DS; Kahook MY; Ramulu PY
Ophthalmology; 2015 Dec; 122(12):2373-9. PubMed ID: 26260280
[TBL] [Abstract][Full Text] [Related]
18. Validation of a short version of the glaucoma medication self-efficacy questionnaire.
Sleath B; Blalock SJ; Stone JL; Skinner AC; Covert D; Muir K; Robin AL
Br J Ophthalmol; 2012 Feb; 96(2):258-62. PubMed ID: 21610264
[TBL] [Abstract][Full Text] [Related]
19. Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population.
Zhu Z; Jiang Y; Wang W; Scheetz J; Shang X; Zhang L; He M
Clin Exp Ophthalmol; 2019 Sep; 47(7):881-891. PubMed ID: 31034700
[TBL] [Abstract][Full Text] [Related]
20. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
